NASDAQ: SLRNAcelyrin Inc Stock Ownership - Who owns Acelyrin?
Insider buying vs selling
Have Acelyrin Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Shaolee Lin | Chief Executive Officer | 2024-04-01 | 9,961 | $6.63 | $66.02kSell |
| Shaolee Lin | Chief Executive Officer | 2024-02-20 | 15,701 | $7.61 | $119.41kSell |
| Shaolee Lin | Chief Executive Officer | 2024-01-02 | 10,691 | $7.41 | $79.19kSell |
| Mardi Dier | CFO and CBO | 2023-05-09 | 5,556 | $18.00 | $100.01kBuy |
| Henry O. Gosebruch | Director | 2023-05-09 | 50,000 | $18.00 | $900.00kBuy |
| Mina Kim | Chief Legal Admin. Officer | 2023-05-09 | 5,000 | $18.00 | $90.00kBuy |
| Shaolee Lin | Chief Executive Officer | 2023-05-09 | 337,179 | $24.69 | $8.32MSell |
| Ronald Oyston | Chief People Officer | 2023-05-09 | 26 | $18.00 | $468.00Buy |
| Ronald Oyston | Chief People Officer | 2023-05-09 | 1,000 | $18.00 | $18.00kBuy |
| Paul Peloso | Chief Medical Officer | 2023-05-09 | 6,000 | $18.00 | $108.00kBuy |
SLRN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SLRN insiders and whales buy or sell their stock.
SLRN Shareholders
What type of owners hold Acelyrin Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Beth C. Seidenberg | 10.01% | 9,850,729 | $41.77M | Insider |
| Westlake Biopartners Fund Ii LP | 9.95% | 9,790,729 | $41.51M | Insider |
| Ayurmaya Capital Management Company LP | 9.49% | 9,334,735 | $39.58M | Insider |
| Ayurmaya Capital Management Company LP | 9.49% | 9,334,735 | $39.58M | Institution |
| Fmr LLC | 8.97% | 8,822,271 | $37.41M | Institution |
| Citadel Advisors LLC | 6.58% | 6,474,048 | $27.45M | Institution |
| Vanguard Group Inc | 6.26% | 6,155,910 | $26.10M | Institution |
| Opaleye Management Inc | 4.22% | 4,146,138 | $17.58M | Institution |
| Orbimed Advisors LLC | 4.07% | 4,001,711 | $16.97M | Institution |
| Venbio Partners LLC | 3.92% | 3,852,470 | $16.33M | Institution |
SLRN vs Biotech Stocks
Acelyrin Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.